Residual Corticosteroid Production in Autoimmune Addison Disease

Author:

Sævik Åse Bjorvatn12ORCID,Åkerman Anna-Karin34,Methlie Paal125,Quinkler Marcus6ORCID,Jørgensen Anders Palmstrøm7ORCID,Höybye Charlotte48ORCID,Debowska Aleksandra J9ORCID,Nedrebø Bjørn Gunnar110ORCID,Dahle Anne Lise10,Carlsen Siri11,Tomkowicz Aneta12,Sollid Stina Therese13ORCID,Nermoen Ingrid14,Grønning Kaja14,Dahlqvist Per15ORCID,Grimnes Guri1617ORCID,Skov Jakob4ORCID,Finnes Trine18ORCID,Valland Susanna F18,Wahlberg Jeanette19ORCID,Holte Synnøve Emblem20,Simunkova Katerina1,Kämpe Olle2821ORCID,Husebye Eystein Sverre12521ORCID,Bensing Sophie48ORCID,øksnes Marianne12521

Affiliation:

1. Department of Clinical Science, University of Bergen, Norway

2. K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway

3. Department of Medicine, Örebro University Hospital, Örebro, Sweden

4. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

5. Department of Medicine, Haukeland University Hospital, Bergen, Norway

6. Endocrinology in Charlottenburg, Berlin, Germany

7. Department of Endocrinology, Oslo University Hospital, Oslo, Norway

8. Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden

9. Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway

10. Department of Internal Medicine, Haugesund Hospital, Haugesund, Norway

11. Department of Endocrinology, Stavanger University Hospital, Stavanger, Norway

12. Department of Medicine, Sørlandet Hospital, Kristiansand, Norway

13. Department of Medicine, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway

14. Department of Endocrinology, Akershus University Hospital, Lørenskog, Norway

15. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

16. Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

17. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT the Arctic University of Norway, Tromsø, Norway

18. Section of Endocrinology, Innlandet Hospital Trust, Hamar, Norway

19. Department of Endocrinology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

20. Department of Medicine, Sørlandet Hospital, Arendal, Norway

21. Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

Abstract

Abstract Context Contrary to current dogma, growing evidence suggests that some patients with autoimmune Addison disease (AAD) produce corticosteroids even years after diagnosis. Objective To determine frequencies and clinical features of residual corticosteroid production in patients with AAD. Design Two-staged, cross-sectional clinical study in 17 centers (Norway, Sweden, and Germany). Residual glucocorticoid (GC) production was defined as quantifiable serum cortisol and 11-deoxycortisol and residual mineralocorticoid (MC) production as quantifiable serum aldosterone and corticosterone after > 18 hours of medication fasting. Corticosteroids were analyzed by liquid chromatography–tandem mass spectrometry. Clinical variables included frequency of adrenal crises and quality of life. Peak cortisol response was evaluated by a standard 250 µg cosyntropin test. Results Fifty-eight (30.2%) of 192 patients had residual GC production, more common in men (n = 33; P < 0.002) and in shorter disease duration (median 6 [0-44] vs 13 [0-53] years; P < 0.001). Residual MC production was found in 26 (13.5%) patients and associated with shorter disease duration (median 5.5 [0.5-26.0] vs 13 [0-53] years; P < 0.004), lower fludrocortisone replacement dosage (median 0.075 [0.050-0.120] vs 0.100 [0.028-0.300] mg; P < 0.005), and higher plasma renin concentration (median 179 [22-915] vs 47.5 [0.6-658.0] mU/L; P < 0.001). There was no significant association between residual production and frequency of adrenal crises or quality of life. None had a normal cosyntropin response, but peak cortisol strongly correlated with unstimulated cortisol (r = 0.989; P < 0.001) and plasma adrenocorticotropic hormone (ACTH; r = –0.487; P < 0.001). Conclusion In established AAD, one-third of the patients still produce GCs even decades after diagnosis. Residual production is more common in men and in patients with shorter disease duration but is not associated with adrenal crises or quality of life.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Autoimmune polyendocrine syndromes;Eisenbarth;N Engl J Med.,2004

2. Does recovery of adrenal function occur in patients with autoimmune Addison’s disease?;Smans;Clin Endocrinol (Oxf).,2011

3. Residual endogenous corticosteroid production in patients with adrenal insufficiency;Vulto;Clin Endocrinol (Oxf).,2019

4. Residual adrenal function in autoimmune Addison’s disease - effect of dual therapy with rituximab and depot tetracosactide;Napier;J Clin Endocrinol Metab,2020;105(4):1250-1259

5. Clinical and immunological characteristics of autoimmune Addison’s disease: a nationwide Swedish multicenter study;Dalin;J Clin Endocrinol Metabo.,2017;102(2):379-389

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3